RedTail Flight Academy Honors Original Tuskegee Airmen Through Graduating Class of 2022 June 3, 2022 4:14 pm|Class Carries on the Legacy of Tuskegee Airmen and Inspires Future Aviators
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES INCREASE IN LEVERAGE June 3, 2022 4:10 pm|NEW YORK, June 3, 2022 /PRNewswire/ — Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the…
Special Olympics drops vaccine rule after Florida’s $27.5M fine threat June 3, 2022 4:09 pm|TALLAHASSEE, Fla. (AP) — The Special Olympics has dropped a coronavirus vaccine mandate for its games in Orlando…
MikeWorldWide Executive to Speak at Ragan's Workplace Wellness Conference about Building Positive Workplace Culture June 3, 2022 4:09 pm|Chief People Officer Gina Cherwin to share her experience as an advocate for working parents and insights on returning…
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) June 3, 2022 4:05 pm|ANDOVER, Mass., June 3, 2022 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that…
ICF to Present at Baird 2022 Global Consumer, Technology & Services Conference June 3, 2022 4:05 pm|FAIRFAX, Va., June 3, 2022 /PRNewswire/ — ICF (NASDAQ:ICFI), a global consulting and digital services provider, today announced…
Carnival crew rescues 16 stranded on small boat in open seas June 3, 2022 4:02 pm|(Gray News) – International cruise line Carnival announced Friday that some of the company’s crew members rescued 16…
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) June 3, 2022 4:01 pm|CAMBRIDGE, Mass., June 3, 2022 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on…
AMGEN ANNOUNCES WEBCAST OF 2022 JEFFERIES HEALTHCARE CONFERENCE June 3, 2022 4:00 pm|THOUSAND OAKS, Calif., June 3, 2022 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the 2022 Jefferies Healthcare Conference…
Arcellx Presents Continued Robust Long-Term Responses from its CART-ddBCMA Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 2022 ASCO Annual Meeting June 3, 2022 4:00 pm|— 100% ORR at both dose levels; deep and durable responses observed in patients with poor prognostic factors —